216 related articles for article (PubMed ID: 38084139)
41. Target and Mechanism of the Xihuang Pill Based on Network Pharmacology for Lung Squamous Cell Carcinoma.
Tu H; Li J; Xu W; Wang Z; Wang L
Altern Ther Health Med; 2023 Oct; 29(7):148-154. PubMed ID: 37442189
[TBL] [Abstract][Full Text] [Related]
42. LncRNA RP11-116G8.5 promotes the progression of lung squamous cell carcinoma through sponging miR-3150b-3p/miR-6870-5p to upregulate PHF12/FOXP4.
Li H; Zhao Q; Tang Z
Pathol Res Pract; 2021 Oct; 226():153566. PubMed ID: 34500373
[TBL] [Abstract][Full Text] [Related]
43. MiR-4652-5p Targets RND1 to Regulate Cell Adhesion and Promote Lung Squamous Cell Carcinoma Progression.
Zhou Y; Yan J; Chen H; Zhou W; Xiao G; Zou H; Yang J
Appl Biochem Biotechnol; 2022 Jul; 194(7):3031-3043. PubMed ID: 35334070
[TBL] [Abstract][Full Text] [Related]
44. Comprehensive analyses of a CD8
Chen L; Weng Y; Cui X; Li Q; Peng M; Song Q
BMC Bioinformatics; 2023 Jun; 24(1):238. PubMed ID: 37280525
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of the HOXA11 level in patients with lung squamous cancer and insights into potential molecular pathways via bioinformatics analysis.
Zhang R; Zhang TT; Zhai GQ; Guo XY; Qin Y; Gan TQ; Zhang Y; Chen G; Mo WJ; Feng ZB
World J Surg Oncol; 2018 Jun; 16(1):109. PubMed ID: 29914539
[TBL] [Abstract][Full Text] [Related]
46. LncRNA PITPNA-AS1 boosts the proliferation and migration of lung squamous cell carcinoma cells by recruiting TAF15 to stabilize HMGB3 mRNA.
Ren P; Xing L; Hong X; Chang L; Zhang H
Cancer Med; 2020 Oct; 9(20):7706-7716. PubMed ID: 32871048
[TBL] [Abstract][Full Text] [Related]
47. PLAU, transcriptionally negatively regulated by GATA6, promotes lung squamous carcinoma cell proliferation and migration.
Guo J; Wang H; Huang C; Lai C; Shang W; Luo S; Chen L
Biochim Biophys Acta Mol Cell Res; 2024 Jun; 1871(5):119744. PubMed ID: 38702016
[TBL] [Abstract][Full Text] [Related]
48. Identification of a Prognostic Model Based on Immune-Related Genes of Lung Squamous Cell Carcinoma.
Li R; Liu X; Zhou XJ; Chen X; Li JP; Yin YH; Qu YQ
Front Oncol; 2020; 10():1588. PubMed ID: 33014809
[TBL] [Abstract][Full Text] [Related]
49. Prediction of lung squamous cell carcinoma immune microenvironment and immunotherapy efficiency with pyroptosis-derived genes.
Deng X; Wang Z; Luo Y; Li Z; Chen L
Medicine (Baltimore); 2022 Sep; 101(37):e30304. PubMed ID: 36123889
[TBL] [Abstract][Full Text] [Related]
50. Comprehensive Analysis of Immune Cell Infiltration of m6a-Related lncRNA in Lung Squamous Cell Carcinoma and Construction of Relevant Prognostic Models.
Zhang P; Li H; Cheng X; Wang W
Biomed Res Int; 2022; 2022():9139823. PubMed ID: 35872842
[TBL] [Abstract][Full Text] [Related]
51. LncRNA PITPNA-AS1/miR-223-3p/PTN axis regulates malignant progression and stemness in lung squamous cell carcinoma.
Peng BH; Ji YF; Qiu XJ
J Clin Lab Anal; 2022 Jul; 36(7):e24506. PubMed ID: 35588441
[TBL] [Abstract][Full Text] [Related]
52. Investigation of miR-136-5p key target genes and pathways in lung squamous cell cancer based on TCGA database and bioinformatics analysis.
Xie ZC; Li TT; Gan BL; Gao X; Gao L; Chen G; Hu XH
Pathol Res Pract; 2018 May; 214(5):644-654. PubMed ID: 29650443
[TBL] [Abstract][Full Text] [Related]
53. [Identification of differentially expressed genes between lung adenocarcinoma and squamous cell carcinoma using transcriber signature analysis].
Peng S; Li X; Liu Q; Zhang Y; Zou L; Gong X; Wang M; Ma X
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Jun; 39(6):641-649. PubMed ID: 31270041
[TBL] [Abstract][Full Text] [Related]
54. Smoking is Associated with Lung Adenocarcinoma and Lung Squamous Cell Carcinoma Progression through Inducing Distinguishing lncRNA Alterations in Different Genders.
Liu B; Liu Y; Zou J; Zou M; Cheng Z
Anticancer Agents Med Chem; 2022; 22(8):1541-1550. PubMed ID: 34315392
[TBL] [Abstract][Full Text] [Related]
55. Bioinformatics-based screening and analysis of the key genes involved in the influence of antiangiogenesis on myeloid-derived suppressor cells and their effects on the immune microenvironment.
Zhao X; Zhao R; Wen J; Zhang X; Wu S; Fang J; Ma J; Gao L; Hu Y
Med Oncol; 2024 Mar; 41(5):96. PubMed ID: 38526604
[TBL] [Abstract][Full Text] [Related]
56. Prediction of risk and clinical outcome of cuproptosis in lung squamous carcinoma.
Zhang Y; Zhou J; Li H; Liu Y; Li J
BMC Pulm Med; 2023 Jun; 23(1):205. PubMed ID: 37308925
[TBL] [Abstract][Full Text] [Related]
57. LncRNA STARD13-AS blocks lung squamous carcinoma cells growth and movement by targeting miR-1248/C3A.
Li G; Guo X
Pulm Pharmacol Ther; 2020 Oct; 64():101949. PubMed ID: 32949706
[TBL] [Abstract][Full Text] [Related]
58. A Hypoxia-Related Signature for Predicting Prognosis, Cellular Processes, Immune Microenvironment and Targeted Compounds in Lung Squamous Cell Carcinoma.
Wu G; Zhu Z; Yang Z; He M; Ren K; Dong Y; Xue Q
Int J Gen Med; 2022; 15():3991-4006. PubMed ID: 35437352
[TBL] [Abstract][Full Text] [Related]
59. The Mechanism of Quercetin in the Treatment of Lung Squamous Cell Carcinoma Based on a Protein-Protein Interaction Network.
Lu Y; Zhang W; Li H; Liu C; Gao D; Zhuang J; Liu R; Wu J; Sun C
Evid Based Complement Alternat Med; 2022; 2022():9985160. PubMed ID: 36605099
[TBL] [Abstract][Full Text] [Related]
60. [LINC00668 is Highly Expressed in Lung Squamous Cell Carcinoma and
Promotes Tumor Cell Migration and Invasion].
Yuan B; Chen Y; Yuan J; Zeng L; Yang S
Zhongguo Fei Ai Za Zhi; 2022 Apr; 25(4):226-235. PubMed ID: 35477186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]